title: Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer.
authors.affiliation: University of California Berkeley and San Francisco Joint Bioengineering Graduate Group, San Francisco, CA 94143, USA. karen@socrates.berkeley.edu
authors.forename: Karen L
authors.initials: KL
authors.lastname: Christman
authors.forename: Qizhi
authors.initials: Q
authors.lastname: Fang
authors.forename: Michael S
authors.initials: MS
authors.lastname: Yee
authors.forename: Kandice R
authors.initials: KR
authors.lastname: Johnson
authors.forename: Richard E
authors.initials: RE
authors.lastname: Sievers
authors.forename: Randall J
authors.initials: RJ
authors.lastname: Lee
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000008:administration & dosage* / Q000235:genetics; D016207:Cytokines / Q000008:administration & dosage* / Q000235:genetics; D004338:Drug Combinations; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000008:administration & dosage*; D018390:Gene Targeting / Q000379:methods; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D018919:Neovascularization, Physiologic / Q000187:drug effects* / Q000235:genetics; D010957:Plasmids / Q000008:administration & dosage*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016896:Treatment Outcome
chemical_list: D002352:Carrier Proteins; D016207:Cytokines; D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; C066845:pleiotrophin